Mersana Therapeutics, Inc. (MRSN) — Analyst outlook / Analyst consensus target is. Based on 19 analyst ratings, the consensus is bullish — 11 Buy, 8 Hold.
The consensus price target is $3.00, representing a downside of 89.7% from the current price $29.08.
MRSN Stock — 12-Month Price Forecast
$3.00
▼ -89.68% Downside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for Mersana Therapeutics, Inc., the price target is $3.00.
The average price target represents a -89.68% change from the last price of $29.08.
MRSN Analyst Ratings
Buy
Based on 19 analysts giving stock ratings to Mersana Therapeutics, Inc. in the past 3 months
